If You Can Only Buy One Biotech Stock in December, It Better Be One of These 3 NamesInvestorPlace • 11/29/23
Editas Medicine, Inc. (EDIT) 6th Annual Evercore ISI HealthCONx Conference (Transcript)Seeking Alpha • 11/28/23
2 Beaten-Down Growth Stocks That Could Rocket 42% to 67% Higher, According to Wall StreetThe Motley Fool • 11/20/23
Editas Medicine, Inc. (EDIT) Presents at Stifel 2023 Healthcare Conference (Transcript)Seeking Alpha • 11/14/23
Editas Medicine to Present Clinical Data from the RUBY and EdiTHAL Trials of EDIT-301 at the ASH 2023 Annual Meeting and in a Company-sponsored WebinarGlobeNewsWire • 11/02/23
Gene Therapy Could Be On the Cusp of a Major Breakthrough, but Investors May Have to Remain PatientThe Motley Fool • 10/30/23
Editas Medicine Announces Third Quarter 2023 Results Conference Call and Upcoming Investor EventsGlobeNewsWire • 10/27/23
Editas Medicine Granted FDA Regenerative Medicine Advanced Therapy (RMAT) Designation for EDIT-301 for the Treatment of Severe Sickle Cell DiseaseGlobeNewsWire • 10/16/23